Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis. (Q48491942)

12 February 2018

title

Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis. (English)

1 reference

12 February 2018

author name string

Shu-Qin Yao

1

1 reference

12 February 2018

Zheng-Zheng Li

2

1 reference

12 February 2018

Qing-Yuan Huang

3

1 reference

12 February 2018

Fang Li

4

1 reference

12 February 2018

Zhao-Wei Wang

5

1 reference

12 February 2018

Elisabete Augusto

6

1 reference

12 February 2018

Jin-Cai He

7

1 reference

12 February 2018

Xiao-Tong Wang

8

1 reference

12 February 2018

Jiang-Fan Chen

9

1 reference

12 February 2018

Rong-Yuan Zheng

10

1 reference

12 February 2018

language of work or name

English

0 references

publication date

23 August 2012

1 reference

12 February 2018

Journal of Neurochemistry

number of pages

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

12 February 2018

volume

123

1 reference

12 February 2018

issue

1

1 reference

12 February 2018

page(s)

100-112

1 reference

12 February 2018

Adenosine is crucial for deep brain stimulation-mediated attenuation of tremor

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Caffeine and an adenosine A(2A) receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Multiple sclerosis: new treatment trials and emerging therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Emerging therapeutic targets in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Detecting axon damage in spinal cord from a mouse model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Neonatal endotoxin exposure suppresses experimental autoimmune encephalomyelitis through regulating the immune cells responsivity in the central nervous system of adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Adenosine A2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Multiple sclerosis: a complicated picture of autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Diagnosis and treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Corticosteroids treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Targeting adenosine A2A receptors in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Glucocorticoids in the control of neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Glucocorticoids regulate innate immunity in a model of multiple sclerosis: reciprocal interactions between the A1 adenosine receptor and beta-arrestin-1 in monocytoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Idazoxan attenuates spinal cord injury by enhanced astrocytic activation and reduced microglial activation in rat experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Genetic and pharmacological inactivation of adenosine A2A receptor reveals an Egr-2-mediated transcriptional regulatory network in the mouse striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07807.X

10.1111/J.1471-4159.2012.07807.X

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

22639925

1 reference

12 February 2018